Biotech Business - August 2, 2021
Hansa Biopharma announces reimbursement in the Netherlands of Idefirix
Hansa Biopharma has announced that its treatment Idefirix is, as of August 1, reimbursable and available for use in the Netherlands. Idefirix is the first and only treatment approved for use in the European Union for desensitization of highly sensitized patients prior to kidney transplantation, allowing them to be considered for a life-altering kidney transplantation […]
Biotech Business - July 28, 2021
Abera Bioscience receives US patent
The patent forms the basis of a new vaccine platform that the company has developed in parallel with existing platforms. The company has received a Notice of Allowance of its patent application “Fusion polypeptides comprising one or more inclusion body tags, methods and uses” by the US Patent Office. A new vaccine platform The new […]
Biotech Business - July 27, 2021
Anocca raises 47 million USD
Anocca has announced the closing of a USD 47 million (SEK 400 million) Series B financing to further advance the company’s industrialised cellular biology platform and progress its pipeline of TCR-T cellular therapies into Phase I/IIa clinical trials. The financing, led by advisor Danske Bank, brings together a group of investors, with Swedbank Robur Ny […]
Agreement - July 19, 2021
IRLAB enters licensing agreement with Ipsen
Ipsen and IRLAB have signed a licensing agreement, providing Ipsen exclusive worldwide development and commercial rights to mesdopetam, a novel dopamine D3-receptor antagonist. “We are excited to enter this licensing agreement with IRLAB. By working in partnership, we aim to bring investigational mesdopetam to people living with Parkinson’s disease experiencing levodopa-induced dyskinesia,” says Howard Mayer, […]
Biotech Business - July 12, 2021
Amniotics raises SEK 60 million
Amniotics, a stem cell therapy company, has raised SEK 60 million through its recent listing on Nasdaq First North Growth Market. The offering was fully subscribed and attracted widespread interest from Swedish investment companies and family offices as well as the general public in Sweden, Norway and Finland, states the company in a press release. […]
Biotech Business - July 7, 2021
Bio-Me secures NOK 10 million
Bio-Me has raised NOK 10 million in a fully subscribed funding round. Both existing and new investors participated in the financing round, with new investors contributing the majority of the capital, states the company in a press release. “We are excited to move forward with our plans to achieve specific value-driving milestones that position PMP […]
